Bioscience News - GEG Tech top picks
8.8K views | +0 today
Follow
Bioscience News - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

Nivolumab With Ipilimumab May Negate Need for Whole Brain Radiotherapy in Melanoma With Brain Metastases

Nivolumab With Ipilimumab May Negate Need for Whole Brain Radiotherapy in Melanoma With Brain Metastases | Bioscience News - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

Combination immunotherapy with nivolumab and ipilimumab provided intracranial and extracranial responses for patients with melanoma and brain metastases, according to data from CheckMate 204 (ClinicalTrials.gov Identifier: NCT02320058) presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance - Cancer Cell

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance - Cancer Cell | Bioscience News - GEG Tech top picks | Scoop.it

Click here to edit the content

BigField GEG Tech's insight:

French researchers have modified a molecule used in the treatment of diabetes to destroy melanoma. This strategy could be used for patients resistant to current therapies.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

AI System as Good as Experts at Recognizing Skin Cancers 

AI System as Good as Experts at Recognizing Skin Cancers  | Bioscience News - GEG Tech top picks | Scoop.it

Computers using image recognition can classify skin cancers as successfully as human experts, according to the latest research attempting to apply artificial intelligence to health care.

BigField GEG Tech's insight:

The US-based researchers say the new system, which is based on image recognition, could be developed for smartphones, increasing access to screening and providing a low-cost way to check whether skin lesions are cause for concern.

No comment yet.